Ankylosing spondylitis, ICD10

M13_ANKYLOSPON_ICD10

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M45 Cause of death: ICD-10 — M45 2 out of 7 registries used, show all original rules.	3729
4. Check minimum number of events None	3729
5. Include endpoints None	3729
6. Filter based on genotype QC (FinnGen only)	3729

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: M45-M49
Name in latin: Spondylarthritis/spondylitis ancylopoetica

NAME	M13_ANKYLOSPON_ICD10
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M45
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M45
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ankylosing spondylitis, ICD10 based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Ankylosing spondylitis, strict definition

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3729	1787	1942
Unadjusted period prevalence (%)	0.74	0.61	0.86
Median age at first event (years)	43.58	41.89	45.13

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3390: Matched controls
33898

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

4.1

323.0

2220

10646

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

62.2

323.0

592

115

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

20.5

323.0

716

438

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

11.4

323.0

875

1003

L04AB01

ATC

etanercept; parenteral

45.6

323.0

523

135

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

81.1

323.0

2739

1673

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

17.6

323.0

1478

1428

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

14.4

323.0

1009

970

L88

ICPC

Rheumatoid/seropositive arthritis

18.3

323.0

648

433

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

833.1

323.0

372

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

75.8

323.0

521

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

27.3

323.0

979

496

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

56.3

323.0

1129

298

M45

ICD-10 Finland

Ankylosing spondylitis

4503599627370496.0

323.0

3361

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

58.4

323.0

1093

274

L04AB04

ATC

adalimumab; parenteral

39.2

323.0

671

212

A07EC01

ATC

sulfasalazine; oral, rectal

74.2

323.0

2476

1193

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

33.9

323.0

500

172

L04AB06

ATC

golimumab; parenteral

63.4

311.3

363

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

13.6

281.5

511

436

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

21.4

272.3

412

218

M01AH01

ATC

celecoxib; oral (coxibs)

4.3

231.3

1039

3156

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

172.1

230.1

240

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

2190.4

225.4

216

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

31.3

218.8

295

103

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.3

196.1

1302

5346

L04AA13

ATC

leflunomide; oral

14.2

195.5

345

268

P01BA02

ATC

hydroxychloroquine; oral

5.8

193.8

603

1209

M01AC06

ATC

meloxicam; systemic, rectal

3.0

186.7

1608

7850

H20.1

ICD-10 Finland

Chronic iridocyclitis

26.1

183.1

259

107

S01FA04

ATC

cyclopentolate; ophthalmic

27.3

178.4

249

M01AH05

ATC

etoricoxib; oral

2.9

177.5

2402

15424

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.9

148.2

397

642

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.2

142.7

608

1667

M13.9

ICD-10 Finland

Arthritis, unspecified

4.9

130.7

472

1091

H02AB07

ATC

prednisone; oral

3.5

130.6

718

2431

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

127.7

1630

9319

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

9.7

121.1

256

282

N02AX02

ATC

tramadol; systemic, rectal

2.4

119.7

1640

9613

S01FA02

ATC

scopolamine; ophthalmic

21.8

119.5

178

L04AC10

ATC

secukinumab; parenteral

35.9

114.0

148

WZA10

NOMESCO Finland

Long statement of health and health related matters

13.8

108.5

192

147

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

40.4

107.6

136

L04AA11

ATC

[U] etanercept; parenteral

40.6

102.2

129

L04AB05

ATC

certolizumab pegol; parenteral

41.2

100.9

127

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

8.3

97.5

226

290

M01AH02

ATC

rofecoxib; oral

3.2

96.6

573

2011

A02BC02

ATC

pantoprazole; systemic

2.2

95.8

2262

16303

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.6

93.0

471

1462

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.2

88.9

536

1893

M01AE02

ATC

naproxen; oral, rectal

2.1

88.1

2053

14442

M01AB01

ATC

indometacin; systemic, rectal

4.0

87.7

381

1035

M01AX17

ATC

nimesulide; oral

2.4

87.5

904

4424

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

8.3

87.0

201

256

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

84.8

1333

7918

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

7.4

83.2

206

292

M01AB55

ATC

diclofenac, combinations; oral

4.1

77.9

325

848

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

14.5

77.8

134

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

27.6

77.4

107

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.2

75.8

309

788

UJF32

NOMESCO Finland

Coloscopy

2.3

75.7

918

4801

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

73.8

1677

11338

L04AX01

ATC

azathioprine; systemic

4.3

73.6

290

716

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

84.1

73.3

M01AX01

ATC

nabumetone; oral

4.8

73.1

259

574

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

10.5

72.2

145

144

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.4

71.9

228

447

K50.8

ICD-10 Finland

Other Crohn disease

9.1

70.5

153

175

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

53.8

70.4

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

8.8

69.2

153

181

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.8

68.6

180

277

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

68.5

1325

8353

M01CB01

ATC

sodium aurothiomalate; parenteral

10.9

67.9

133

126

M54.5

ICD-10 Finland

Low back pain

2.0

67.1

1199

7315

M05BA04

ATC

alendronic acid; oral

4.0

66.8

288

771

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

6.5

65.1

176

282

M03BX02

ATC

tizanidine; oral

1.9

65.0

2203

16835

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.4

62.5

154

216

TNG10

NOMESCO Finland

Puncture of knee

12.0

62.1

116

100

A02BC03

ATC

lansoprazole; oral

2.0

61.6

1006

5880

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

61.1

329

1055

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.5

61.1

227

527

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

60.5

424

1629

M25.5

ICD-10 Finland

Pain in joint

2.0

58.3

1035

6219

A07EC02

ATC

mesalazine; oral, rectal

3.4

57.5

302

949

H02AB04

ATC

methylprednisolone; systemic

2.4

56.6

558

2594

L04AA01

ATC

[U] ciclosporin; systemic

8.3

55.2

126

157

ZX120

NOMESCO Finland

Intravenous

2.8

55.1

396

1540

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

54.9

393

1526

K50.0

ICD-10 Finland

Crohn disease of small intestine

7.7

53.5

128

172

XX9XE

NOMESCO Finland

Other ultrasound examination

11.4

52.9

101

L04AA17

ATC

[U] adalimumab; parenteral

26.6

52.6

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

51.8

397

1602

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

51.0

933

5619

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

111.8

50.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

50.7

599

3022

R4110

NOMESCO Finland

Physiotherapy

1.9

50.6

903

5385

ZX140

NOMESCO Finland

Intra articular

12.3

50.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

48.3

1380

9589

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.7

48.0

359

1425

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

47.0

1309

9000

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

10.0

46.8

M01AB05

ATC

diclofenac; systemic, rectal

1.7

45.8

2251

18198

N02BE01

ATC

paracetamol; systemic, rectal

1.9

45.4

2809

24374

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.2

44.8

249

813

K50.9

ICD-10 Finland

Crohn disease, unspecified

6.6

44.3

117

182

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.3

43.3

168

406

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.7

43.2

328

1311

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.2

43.2

243

798

M01CB03

ATC

auranofin; oral

13.4

43.1

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

41.3

42.6

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.9

42.0

283

1049

4AB02

NOMESCO Finland

16.7

41.6

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

41.2

326

1334

N03AX16

ATC

pregabalin; oral

1.8

40.3

776

4691

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.5

39.9

122

229

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

39.2

857

5393

A02BC05

ATC

esomeprazole; systemic

1.7

38.8

1276

9060

A07EA06

ATC

budesonide; oral, local oral

3.8

38.4

173

479

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.8

38.3

170

465

Z3226

NOMESCO Finland

Physiotherapist

1.9

38.1

619

3513

N06AA09

ATC

amitriptyline; systemic

2.4

37.6

335

1459

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.1

37.4

122

247

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.7

36.8

951

6280

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

10.1

36.2

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

36.0

985

6608

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

35.9

375

1765

K50.1

ICD-10 Finland

Crohn disease of large intestine

6.5

35.2

149

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

35.0

293

1231

A02BC01

ATC

omeprazole; systemic

1.7

34.7

831

5349

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

5.4

34.3

106

202

L40.5

ICD-10 Finland

Arthropathic psoriasis

5.2

34.3

110

219

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

9.4

34.0

M07.3

ICD-10 Finland

Other psoriatic arthropathies

7.1

33.4

119

M35.7

ICD-10 Finland

Hypermobility syndrome

6.4

33.2

142

N03AX12

ATC

gabapentin; oral

2.0

33.0

499

2742

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.9

33.0

217

793

H20

ICD-10 Finland

Iridocyclitis

14.3

32.4

H57.1

ICD-10 Finland

Ocular pain

3.6

32.4

151

431

M01AC01

ATC

piroxicam; systemic, rectal

2.0

32.0

440

2327

M46.0

ICD-10 Finland

Spinal enthesopathy

29.0

32.0

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

31.6

231

901

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

7.7

31.5

K51.5

ICD-10 Finland

Left sided colitis

3.6

31.4

150

436

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.8

31.4

107

228

J01CA04

ATC

amoxicillin; systemic

1.6

30.7

2639

23188

H02AB08

ATC

triamcinolone; systemic

18.3

30.5

H15.1

ICD-10 Finland

Episcleritis

5.2

30.4

192

S01BC03

ATC

diclofenac; ophthalmic

4.1

30.2

121

303

J01MA02

ATC

ciprofloxacin; systemic

1.6

29.9

1159

8431

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

8.4

29.7

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.7

29.5

133

369

J01DB01

ATC

cefalexin; oral

1.6

29.3

2682

23745

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

6.3

29.2

128

S01ED01

ATC

timolol; ophthalmic

3.9

29.2

125

332

M01AB08

ATC

etodolac; oral

2.4

29.1

265

1164

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

11.2

29.0

M02AA07

ATC

piroxicam; topical

1.6

28.3

1037

7414

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

28.1

334

1661

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

27.4

28.0

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

7.3

27.7

L03

ICPC

Low back symptom/complaint

1.7

27.5

719

4697

M54.6

ICD-10 Finland

Pain in thoracic spine

2.4

27.4

248

1082

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.8

27.4

202

4AA12

NOMESCO Finland

13.1

27.4

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

27.3

318

1566

L84

ICPC

Back syndrome without radiat pain

3.0

27.1

163

563

K02.1

ICD-10 Finland

Caries of dentine

1.5

26.8

1873

15408

RK220

NOMESCO Finland

13.7

26.7

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.4

26.4

229

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.8

26.3

189

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

11.9

26.2

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

37.0

26.1

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

21.3

26.0

L02

ICPC

Back symptom/complaint

2.1

26.0

298

1456

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

6.4

25.9

110

NG1DA

NOMESCO Finland

X-ray of knees

4.8

25.7

185

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

25.6

2071

17485

SPAT1325

SPAT

Vaccination

1.6

25.4

918

6509

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

10.1

25.2

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.9

24.9

104

271

L04AD01

ATC

ciclosporin; systemic

4.2

24.9

233

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

24.6

659

4321

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

24.5

790

5438

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

24.4

2280

19723

N06AX21

ATC

duloxetine; oral

2.0

24.1

349

1875

M54.8

ICD-10 Finland

Other dorsalgia

2.9

23.9

150

533

J01AA02

ATC

doxycycline; systemic

1.5

23.8

2427

21308

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

15.2

23.7

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

23.6

902

6459

J01FA06

ATC

roxithromycin; oral

1.5

23.4

1220

9346

N02AC04

ATC

dextropropoxyphene; oral

3.3

23.3

118

361

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

23.3

1066

7943

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.9

23.2

M01AE52

ATC

naproxen and esomeprazole; oral

3.1

23.2

129

423

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

6.7

23.2

NAJ12

NOMESCO Finland

Posterior reduction of fracture of cervical spine

28.4

23.1

P01AB01

ATC

metronidazole; oral, rectal

1.5

23.1

1179

8988

L99

ICPC

Musculoskeletal disease other

4.7

23.1

175

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

13.0

22.9

Z2221

NOMESCO Finland

Medical doctor

1.5

22.9

838

5935

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

7.5

22.9

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

22.6

616

4046

M01AA01

ATC

phenylbutazone; systemic, rectal

120.8

22.6

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

6.6

22.5

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

22.5

1669

13687

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.4

1187

9105

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

22.1

279

1421

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.8

22.1

255

NF1DA

NOMESCO Finland

X-ray of hips

4.1

21.8

209

Z3231

NOMESCO Finland

Registered nurse

1.5

21.7

795

5617

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

21.7

1850

15528

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

4.8

21.6

151

A02BB01

ATC

misoprostol; oral

11.2

21.4

Z50.1

ICD-10 Finland

Other physical therapy

2.4

21.1

179

756

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

6.0

21.0

M02.1

ICD-10 Finland

Postdysenteric arthropathy

16.7

20.9

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

20.9

115

375

S01FA06

ATC

tropicamide; ophthalmic

24.3

20.8

M79.7

ICD-10 Finland

Fibromyalgia

3.1

20.8

119

398

K07.60

ICD-10 Finland

Snapping jaw

2.4

20.7

180

773

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.5

20.6

164

670

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

20.6

432

2630

M79.6

ICD-10 Finland

Pain in limb

1.5

20.4

1028

7763

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

20.4

132

477

K51.8

ICD-10 Finland

Other ulcerative colitis

4.2

20.4

189

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.8

20.2

132

481

L28

ICPC

Limited function/disability (L)

1.8

20.2

368

2140

M13.0

ICD-10 Finland

Polyarthritis, unspecified

5.2

20.1

124

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

19.9

864

6322

B01AB05

ATC

enoxaparin; parenteral

1.5

19.8

809

5840

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

19.7

259

1341

R42

ICD-10 Finland

Dizziness and giddiness

1.6

19.6

547

3603

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

19.5

1149

8934

R51.80

ICD-10 Finland

Headache

1.7

19.5

449

2803

RK210

NOMESCO Finland

14.7

19.4

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

5.9

19.3

M13.8

ICD-10 Finland

Other specified arthritis

5.8

19.1

A02BA02

ATC

ranitidine; systemic

1.6

19.1

533

3509

71490

ICD-8 Finland

Other specified forms of arthritis, Arthritis postinfectiosa NUD

14.0

19.0

M48.0

ICD-10 Finland

Spinal stenosis

1.9

19.0

297

1639

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

19.0

1730

14536

M54.2

ICD-10 Finland

Cervicalgia

2.1

19.0

228

1138

R03AC02

ATC

salbutamol; inhalant

1.4

18.8

1579

13070

N02AA05

ATC

oxycodone; systemic

1.8

18.7

364

2160

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

18.7

429

2677

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

18.6

509

3331

SPAT1153

SPAT

Removal of sutures

1.5

18.6

873

6478

A07EA02

ATC

hydrocortisone; rectal

3.1

18.6

102

333

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

18.5

585

3969

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.8

18.3

214

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

25.2

18.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

18.2

211

1037

ZXE00

NOMESCO Finland

One hour or less

1.4

18.1

1148

9019

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

18.0

436

2759

SPAT1263

SPAT

Sampling

1.4

18.0

1216

9664

J01FF01

ATC

clindamycin; systemic

1.5

18.0

817

6015

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

52.8

17.9

UJF92

NOMESCO Finland

Capsular endoscopy

3.4

17.7

251

H221, M084

ICD-10 Finland

+∞

17.7

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

17.7

1494

12329

R06.0

ICD-10 Finland

Dyspnoea

1.5

17.3

653

4612

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

17.3

234

1224

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.6

17.3

220

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

17.2

381

2351

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.0

17.2

334

R50.9

ICD-10 Finland

Fever, unspecified

1.7

17.1

401

2511

J01FA10

ATC

azithromycin; systemic

1.4

17.1

1794

15312

ZXA00

NOMESCO Finland

Right side

1.5

17.0

704

5074

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

22.0

16.8

E0000UV

ATC

1.4

16.8

1126

8904

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

16.8

350

2121

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

16.8

1314

10673

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

7.8

16.8

D06BB04

ATC

podophyllotoxin; topical

2.1

16.7

193

944

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.1

16.7

308

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

16.6

1224

9832

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

16.6

200

999

S18

ICPC

Laceration/cut

1.4

16.6

1148

9125

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.9

16.5

173

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

8.3

16.5

Z01.2

ICD-10 Finland

Dental examination

1.4

16.3

1229

9903

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

16.3

1169

9342

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

16.2

1358

11132

WZA90

NOMESCO Finland

Other doctors statement

1.5

16.2

666

4784

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

16.2

638

4542

H20.8

ICD-10 Finland

Other iridocyclitis

9.8

16.1

NDL52

NOMESCO Finland

Tenosynovectomy of hand

6.7

16.0

F01

ICPC

Eye pain

3.0

16.0

323

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.6

15.9

114

440

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

6.9

15.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

15.9

697

5075

J01DA01

ATC

[U] cefalexin; systemic

1.3

15.7

1902

16506

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

15.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.9

15.3

315

Z2446

NOMESCO Finland

Social worker

2.0

15.3

200

1031

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.7

15.2

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

15.1

472

3181

WZC30

NOMESCO Finland

Teaching

1.6

15.1

384

2462

D05AX52

ATC

calcipotriol, combinations; topical

2.1

15.0

181

906

D07XC01

ATC

betamethasone, combinations; topical

1.7

15.0

347

2168

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.8

14.8

170

7202A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Sacro-iliitis, not elsewhere classified

56.9

14.8

S01ED51

ATC

timolol, combinations; ophthalmic

2.1

14.7

172

848

RT272

NOMESCO Finland

10.4

14.7

C10AC01

ATC

colestyramine; oral

2.8

14.7

330

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

9.7

14.7

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.6

526

3663

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

14.5

307

1867

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

14.5

1547

13100

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

150.6

14.5

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

14.4

530

3711

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.1

14.3

136

A07EA01

ATC

prednisolone; rectal

7.1

14.3

R2110

NOMESCO Finland

Giving the first information

1.9

14.2

208

1119

D07AC01

ATC

betamethasone; topical

1.4

14.2

945

7420

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

14.1

142

656

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

14.1

481

3310

S01FA01

ATC

atropine; ophthalmic

6.5

14.1

UKC02

NOMESCO Finland

Cystoscopy

1.6

14.1

398

2616

L17

ICPC

Foot/toe symptom/complaint

1.5

14.1

642

4697

H26.2

ICD-10 Finland

Complicated cataract

4.0

14.0

139

A01

ICPC

Pain general/multiple sites

1.9

13.9

200

1070

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

13.9

175

889

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

13.9

250

1443

G44.2

ICD-10 Finland

Tension-type headache

1.6

13.9

360

2314

L34

ICPC

Musculoskeletal, Blood test

30.1

13.9

NA6CF

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with median intensity magnet

30.1

13.9

M01AH03

ATC

valdecoxib; oral

2.0

13.9

189

991

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

13.8

772

5868

M02.8

ICD-10 Finland

Other reactive arthropathies

7.1

13.8

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

13.8

594

4297

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.8

1537

13063

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

13.7

293

1784

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

13.7

937

7376

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.4

13.6

188

SPAT1202

SPAT

Intra-articular injection

2.7

13.6

344

M46

ICD-10 Finland

Other inflammatory spondylopathies

+∞

13.5

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

13.4

230

1310

WX320

NOMESCO Finland

Spinalanesthesy

1.5

13.4

588

4265

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

13.4

175

WX290

NOMESCO Finland

Other blockade of nerve

1.3

13.3

1393

11707

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

21.2

13.3

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

8.1

13.3

R01AD08

ATC

fluticasone; nasal

1.4

13.3

824

6380

M05BA01

ATC

etidronic acid; systemic

10.5

13.2

L13

ICPC

Hip symptom/complaint

1.6

13.2

352

2281

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

13.1

220

1242

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

13.1

177

923

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

7.9

13.1

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.6

13.1

385

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.5

13.0

169

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

12.9

474

3313

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

5.5

12.8

M05BA07

ATC

risedronic acid; oral

3.0

12.8

245

RF120

NOMESCO Finland

3.9

12.8

131

71599

ICD-8 Finland

Arthritis, unspecified

8.1

12.8

RT271

NOMESCO Finland

11.6

12.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.9

12.8

136

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

14.1

12.7

M54

ICD-10 Finland

Dorsalgia

1.6

12.7

317

2017

J01FA09

ATC

clarithromycin; systemic

1.4

12.7

917

7272

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.5

12.6

173

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

12.6

193

1059

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

12.6

250

1492

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

7.0

12.5

S01EC01

ATC

acetazolamide; systemic

3.2

12.5

201

J99.8*M45

ICD-10 Finland

Respiratory disorders in ankylosing spondylitis

+∞

12.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

12.5

1396

11808

M02AA10

ATC

ketoprofen; topical

1.5

12.4

416

2847

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

12.4

112

494

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

7.6

12.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

12.4

124

572

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

12.3

182

M16.7

ICD-10 Finland

Other secondary coxarthrosis

4.9

12.3

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

37.7

12.2

RF420

NOMESCO Finland

3.4

12.2

173

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

12.2

322

2078

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.5

12.1

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

4.5

12.1

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.3

12.0

186

R07.3

ICD-10 Finland

Other chest pain

1.7

11.9

241

1444

RF410

NOMESCO Finland

3.6

11.9

150

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.3

11.9

N05CF01

ATC

zopiclone; oral

1.4

11.9

811

6359

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.7

11.9

244

1472

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

11.8

306

1964

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

6.4

11.8

R05

ICD-10 Finland

Cough

1.5

11.8

491

3520

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.4

11.7

168

C03CA01

ATC

furosemide; systemic

1.4

11.7

558

4107

3029

Kela drug reimbursment

Upadacitinib

30.1

11.6

L01

ICPC

Neck symptom/complaint

1.5

11.6

355

2379

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

11.6

751

5834

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.5

11.6

355

NDG30

NOMESCO Finland

Fusion of wrist, total

6.5

11.5

J01MA12

ATC

levofloxacin; systemic

1.5

11.5

476

3406

H221, M083

ICD-10 Finland

120.4

11.4

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

120.4

11.4

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.4

466

3327

L01CB

ATC

Podophyllotoxin derivatives

11.8

11.3

H26.3

ICD-10 Finland

Drug-induced cataract

5.6

11.3

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

11.3

296

1909

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

8.3

11.3

KMAK

NOMESCO Finland

1.3

11.3

1602

13932

J02AC01

ATC

fluconazole; systemic

1.3

11.2

1071

8820

WX110

NOMESCO Finland

Local anesthesy

1.3

11.2

2117

19096

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

9.6

11.2

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

11.2

111

510

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

11.2

983

8000

L04AC05

ATC

ustekinumab; parenteral

6.2

11.2

L01BB02

ATC

mercaptopurine; oral

3.7

11.1

128

71498

ICD-8 Finland

Other specified forms of arthritis, Alia definita

20.1

11.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

11.1

253

1572

ZXA05

NOMESCO Finland

Left side

1.4

11.1

621

4701

H02BX01

ATC

methylprednisolone, combinations; systemic

2.0

11.1

132

660

D07AD01

ATC

clobetasol; topical

1.5

11.1

393

2721

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

11.0

516

3782

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

11.0

616

4661

M02.3

ICD-10 Finland

Reiter disease

10.1

11.0

4AB0M

NOMESCO Finland

43.4

10.9

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

6.0

10.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

10.8

125

617

-50

ICPC

Medication/prescr/renewal

2.2

10.7

113

535

H30.2

ICD-10 Finland

Posterior cyclitis

8.8

10.7

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

10.6

390

R60.0

ICD-10 Finland

Localized oedema

1.6

10.6

253

1588

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

10.6

512

3773

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

6.3

10.6

NA2AD

NOMESCO Finland

Thoracic spine CT examination

5.5

10.5

RK250

NOMESCO Finland

6.2

10.4

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

110.3

10.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

10.3

147

785

SPAT1301

SPAT

No procedures

1.3

10.3

814

6507

L86

ICPC

Back syndrome with radiating pain

1.9

10.3

147

786

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.3

834

6693

JF1BD

NOMESCO Finland

Very extensive small bowel CT

5.5

10.2

M01CC01

ATC

penicillamine; oral

23.4

10.2

-1

NOMESCO Finland

1.3

10.1

970

7973

RS221

NOMESCO Finland

3.0

10.1

183

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.1

647

5008

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

10.0

115

568

TNF10

NOMESCO Finland

Puncture of hip joint

14.6

10.0

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.3

10.0

387

SPAT1260

SPAT

Consultation of another employee

1.4

9.9

440

3188

H26.4

ICD-10 Finland

After-cataract

1.8

9.9

157

874

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.8

9.8

160

897

L16

ICPC

Ankle symptom/complaint

1.6

9.8

249

1592

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

9.8

1059

8837

L04AC07

ATC

tocilizumab; parenteral

8.7

9.8

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.2

9.7

464

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

9.7

1067

8917

AA1AD

NOMESCO Finland

CT of head and brain

1.4

9.7

568

4323

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

9.7

184

1084

1008

NOMESCO Finland

13.4

9.7

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

9.6

108

528

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.4

9.6

334

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.4

9.5

R52.2

ICD-10 Finland

Other chronic pain

2.2

9.5

443

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

9.5

152

850

M19.2

ICD-10 Finland

Other secondary arthrosis

3.3

9.5

136

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.4

9.5

131

E000001

ATC

1.4

9.4

543

4122

7113L

ICD-9 Finland

Arthropathy associated with infections, Postdysenteric arthropathy[ENTEROARTHRITIS, USEAT NIVELET]

100.3

9.4

4AB0X

NOMESCO Finland

30.1

9.4

SPAT1255

SPAT

Intravenous administration of medicine

1.8

9.3

167

968

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

9.3

603

4668

SPAT1229

SPAT

Assessment of need for aid

1.7

9.3

170

993

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

9.3

301

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

9.3

110

552

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.7

9.3

230

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.3

9.2

139

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

9.1

2909

27676

L15

ICPC

Knee symptom/complaint

1.4

9.1

489

3670

M54.1

ICD-10 Finland

Radiculopathy

2.0

9.1

106

529

M06

ICD-10 Finland

Other rheumatoid arthritis

5.3

9.0

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

9.0

144

803

D07AC13

ATC

mometasone; topical

1.3

9.0

780

6301

J20

ICD-10 Finland

Acute bronchitis

1.6

9.0

247

1614

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

9.0

130

702

XKD00

NOMESCO Finland

Uroflowmetry

1.5

8.9

356

2523

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.6

8.9

234

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

24.1

8.9

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

6.1

8.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

8.9

232

1496

R06AE07

ATC

cetirizine; oral

1.3

8.9

1218

10442

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

12.5

8.9

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

8.8

195

1204

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

8.8

1001

8383

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.5

8.8

112

J05AB01

ATC

aciclovir; systemic

1.4

8.8

532

4066

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

8.8

298

2043

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.2

8.8

404

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

8.7

231

1495

G04CA02

ATC

tamsulosin; oral

1.4

8.6

499

3790

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.8

8.6

RT171

NOMESCO Finland

8.2

8.6

A06AD11

ATC

lactulose; oral

1.5

8.5

282

1923

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.3

8.5

126

M05BA06

ATC

ibandronic acid; systemic

3.3

8.5

126

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.5

833

6836

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

8.5

748

6050

ZY010

NOMESCO Finland

Hospital outpatient

1.8

8.5

138

777

S01EC04

ATC

brinzolamide; ophthalmic

2.3

8.5

324

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

8.5

842

6927

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

8.5

427

3165

N20.0

ICD-10 Finland

Calculus of kidney

2.5

8.4

267

M79.1

ICD-10 Finland

Myalgia

1.5

8.4

326

2297

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

8.4

146

836

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

2.7

8.4

207

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.4

714

5747

N06AX11

ATC

mirtazapine; oral

1.3

8.4

843

6943

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.4

8.4

112

C07AB02

ATC

metoprolol; systemic

1.4

8.4

423

3137

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

8.3

555

4308

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

7.9

8.3

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

6.7

8.3

L04AC13

ATC

ixekizumab; parenteral

6.7

8.3

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.6

8.3

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

8.3

199

1256

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

8.3

780

6366

RS222

NOMESCO Finland

3.2

8.3

129

C07AB07

ATC

bisoprolol; oral

1.3

8.3

1092

9298

M17.5

ICD-10 Finland

Other secondary gonarthrosis

3.1

8.2

135

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

8.2

403

2969

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.4

8.2

ZXA10

NOMESCO Finland

Bilateral

1.4

8.2

417

3094

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

14.5

8.2

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

8.1

453

H40.0

ICD-10 Finland

Glaucoma suspect

1.7

8.1

161

962

M04AA01

ATC

allopurinol; systemic

1.5

8.1

270

1844

ZXD05

NOMESCO Finland

Urgent procedure

1.3

8.1

846

6993

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

8.1

284

1960

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.1

585

4599

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

8.0

105

549

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

8.0

128

715

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.7

8.0

169

1031

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.2

8.0

354

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

8.0

172

1055

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

6.3

8.0

WX212

NOMESCO Finland

Femoral plexus blockade

2.9

8.0

159

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.0

8.0

102

528

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

8.0

188

1183

L04AA24

ATC

abatacept; parenteral

5.9

8.0

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.5

8.0

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.7

8.0

161

968

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

7.9

112

601

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

7.9

152

903

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

7.9

529

4109

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

7.9

509

WX707

NOMESCO Finland

Fiberoscopic intubation

6.6

7.9

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

6.6

7.9

7168A

ICD-9 Finland

Other and unspecified arthropathies, Other specified arthropathy

13.0

7.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

7.9

162

981

G47.3

ICD-10 Finland

Sleep apnoea

1.3

7.9

590

4662

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

7.9

150

889

M01AB16

ATC

aceclofenac; oral

2.1

7.8

412

R5120

NOMESCO Finland

Preparation of an aid

2.3

7.8

280

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.7

7.8

R07.0

ICD-10 Finland

Pain in throat

1.7

7.8

158

955

RT350

NOMESCO Finland

9.4

7.8

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

9.4

7.8

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

7.8

189

1199

J05AB11

ATC

valaciclovir; oral

1.4

7.8

331

2377

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

7.7

104

547

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

7.7

195

1247

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

7.7

140

816

F02

ICPC

Red eye

1.9

7.7

106

563

M81.8

ICD-10 Finland

Other osteoporosis

5.0

7.7

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

5.6

7.7

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.2

7.7

115

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.7

708

5757

L45

ICPC

Musculoskeletal, Observ/health educat/advice/diet

18.4

7.6

114

Kela drug reimbursment

Glaucoma

1.7

7.6

158

962

RF310

NOMESCO Finland

6.7

7.6

13603

ICD-8 Finland

Other and unspecified infective and parasitic diseases, Morbus Reiter, syndroma urethro-oculo-articularis

25.1

7.6

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.9

7.5

291

Kela drug reimbursment

Tofacitinib

8.9

7.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

7.5

232

1559

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

7.5

165

1017

R4180

NOMESCO Finland

Podiatric therapy

3.4

7.5

101

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

7.5

221

1470

R5599

NOMESCO Finland

Other rehabilitation service

2.2

7.5

318

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

7.5

266

1844

R01AD09

ATC

mometasone; nasal

1.2

7.4

1272

11120

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

7.4

664

5370

K92.1

ICD-10 Finland

Melaena

1.9

7.4

104

558

R4120

NOMESCO Finland

Occupational therapy

1.7

7.4

158

968

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.4

302

2153

C08CA05

ATC

nifedipine; systemic

1.7

7.4

132

768

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

7.4

268

1862

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

7.4

241

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

13.4

7.4

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.1

7.4

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

5.6

7.4

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

7.3

122

695

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

7.3

275

VALMI

NOMESCO Finland

1.3

7.2

671

5451

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

3.6

7.2

SBB10

NOMESCO Finland

Teeth copy

1.7

7.2

149

902

S01FB01

ATC

phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)

15.8

7.2

K50

ICD-10 Finland

Crohn disease [regional enteritis]

5.8

7.2

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.2

663

5382

L04AA44

ATC

upadacitinib; oral

30.1

7.1

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

7.1

131

768

4AA24

NOMESCO Finland

20.0

7.1

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

20.0

7.1

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

7.1

321

2333

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

7.9

7.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.1

295

2111

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.0

7.1

128

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

7.0

244

1683

N20.1

ICD-10 Finland

Calculus of ureter

1.9

7.0

103

563

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

7.0

132

780

D01

ICPC

Abdominal pain/cramps general

1.5

7.0

252

1749

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.7

7.0

167

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.9

7.0

102

554

9256

FHL

Synovectomy (knee 9311)

7.0

H25.8

ICD-10 Finland

Other senile cataract

1.6

7.0

171

1085

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

7.0

117

667

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

7.0

138

828

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.2

6.9

290

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

6.9

203

1348

N06AX16

ATC

venlafaxine; oral

1.4

6.9

366

2733

JFB20

NOMESCO Finland

Ileocaecal resection

5.2

6.9

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.3

6.9

250

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

5.8

6.9

SPAT1216

SPAT

Assessment of functional ability

1.4

6.9

299

2157

D01AE16

ATC

amorolfine; topical

1.5

6.9

263

1849

R35

ICD-10 Finland

Polyuria

1.7

6.9

146

896

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

6.9

650

5295

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

6.9

184

1197

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

6.9

644

5241

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

6.8

737

6102

M01AC02

ATC

tenoxicam; systemic, rectal

1.8

6.8

107

599

M01AG01

ATC

mefenamic acid; oral

2.1

6.8

352

B80

ICPC

Iron deficiency anaemia

2.4

6.8

215

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

6.7

6.8

M50.8

ICD-10 Finland

Other cervical disc disorders

5.0

6.8

S01BC05

ATC

ketorolac; ophthalmic

2.1

6.8

367

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.8

529

4195

NDF10

NOMESCO Finland

Synovectomy of wrist

9.3

6.8

-44

ICPC

Preventive immunization/medic

1.6

6.8

180

1169

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

5.3

6.8

NA6DG

NOMESCO Finland

Sacro-iliac joint very extensive MRI examination with high intensity magnet

40.1

6.8

M05.0

ICD-10 Finland

Felty syndrome

16.7

6.7

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

6.7

240

1667

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.7

6.7

131

785

M54.3

ICD-10 Finland

Sciatica

1.6

6.7

147

908

RF431

NOMESCO Finland

22.5

6.7

0108

NOMESCO Finland

22.5

6.7

M07.2

ICD-10 Finland

Psoriatic spondylitis

22.5

6.7

J01MA14

ATC

moxifloxacin; systemic

1.5

6.7

215

1462

L04AA29

ATC

tofacitinib; oral

6.4

6.6

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.8

6.6

101

560

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.6

356

2666

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.2

6.6

296

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

5.9

6.6

L40.8

ICD-10 Finland

Other psoriasis

3.4

6.6

F29

ICPC

Eye symptom/complaint other

1.5

6.6

187

1235

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.6

324

2395

N07CA01

ATC

betahistine; oral

1.6

6.5

157

992

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

6.5

301

2193

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.5

6.5

189

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

6.5

108

616

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.5

271

1938

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.2

6.5

102

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

6.5

361

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.4

6.4

210

RF210

NOMESCO Finland

1.9

6.4

428

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

6.4

257

1827

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

14.3

6.4

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

6.4

878

7469

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

6.4

186

1235

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

6.4

535

4287

D05AX02

ATC

calcipotriol; topical

1.8

6.4

524

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.3

288

S21

ICPC

Skin texture symptom/complaint

1.4

6.3

271

1953

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

6.3

178

1174

R11

ICD-10 Finland

Nausea and vomiting

1.5

6.3

175

1150

D01AC02

ATC

miconazole; topical

1.5

6.3

184

1223

L85

ICPC

Acquired deformity of spine

5.9

6.3

SPAT1312

SPAT

General health counselling

1.2

6.3

812

6858

298

Kela drug reimbursment

18.0

6.3

C08CA01

ATC

amlodipine; oral

1.2

6.3

782

6579

NA6CM

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with 3 Tesla magnet

+∞

6.2

M49

ICD-10 Finland

Spondylopathies in diseases classified elsewhere

+∞

6.2

7200A

ICD-10 Finland

+∞

6.2

N06AB04

ATC

citalopram; systemic

1.3

6.2

539

4333

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

6.2

278

2019

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

3.0

6.2

106

TEG00

NOMESCO Finland

Punction of mandibular joint

7.0

6.2

NHG82

NOMESCO Finland

Fusion of other tarsal joint

3.4

6.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

6.2

181

1207

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.2

184

1232

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.1

170

1116

S01EE03

ATC

bimatoprost; ophthalmic

2.5

6.1

184

H05AA02

ATC

teriparatide; parenteral

5.3

6.1

P01BA01

ATC

chloroquine; systemic

5.7

6.1

RF214

NOMESCO Finland

7.7

6.1

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.1

548

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.3

6.1

215

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

6.1

168

1103

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

4.0

6.1

SFA00

NOMESCO Finland

Small filling

1.4

6.1

330

2476

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

12.5

6.1

7118L

ICD-9 Finland

Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, USEAT NIVELET]

12.5

6.1

M05BX04

ATC

denosumab; parenteral

1.9

6.1

445

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.9

6.1

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.1

2119

19711

NAJ22

NOMESCO Finland

Posterior reduction of fractrue of thoracic spine

8.6

6.0

A60

ICPC

General and Unspecified, Result test/procedure

1.8

6.0

524

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3.0

6.0

103

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

6.0

242

1722

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3006504) Eosinophils/100 leukocytes in Blood

2720

14160

4.40

307.65

12.3

6.1

2.7

2.9

4.26

2635

13259

(3006315) Basophils [#/volume] in Blood

2953

15196

5.53

307.65

11.9

6.0

e9/l

0.0

3.26

2797

13218

(3019198) Lymphocytes [#/volume] in Blood

2972

15610

5.45

307.65

12.0

6.0

e9/l

2.0

1.9

2.35

2839

13861

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

693

991

8.36

307.65

1.6

iu/ml

0.7

7.4

0.52

175

187

(3018010) Neutrophils/100 leukocytes in Blood

2734

14484

4.33

307.65

11.9

6.0

55.7

56.9

7.15

2643

13635

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

230

31.36

307.65

1.6

1.9

au/ml

170.9

68.3

—

(3019069) Monocytes/100 leukocytes in Blood

2730

14245

4.42

307.65

12.7

6.4

8.8

8.6

4.72

2642

13417

(3001604) Monocytes [#/volume] in Blood

2944

15147

5.48

307.65

11.8

5.9

e9/l

0.6

3.68

2785

13185

(3022096) Basophils/100 leukocytes in Blood

2679

13730

4.38

307.65

12.5

6.1

0.7

6.94

2595

12879

(3013650) Neutrophils [#/volume] in Blood by Automated count

3079

17420

5.40

307.65

14.2

9.3

e9/l

3.9

4.1

6.51

2909

15264

(42870588) Differential panel, method unspecified - Blood

2285

10032

4.30

307.65

10.7

6.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

2750

14677

4.33

307.65

12.5

6.1

30.1

28.4

15.11

2658

13769

(3013115) Eosinophils [#/volume] in Blood

2989

15733

5.53

307.65

12.1

6.2

e9/l

0.2

3.14

2858

13934

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

262

106

26.51

307.65

1.7

2.3

mg/l

9.3

0.04

207

(3013707) Erythrocyte sedimentation rate by Westergren method

3366

22111

6.37

301.42

9.6

3.8

mm/h

12.2

10.7

9.17

3276

20641

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3297

22808

4.85

237.62

11.6

7.4

u/l

74.6

76.5

2.22

3210

21629

(3037467) Urinalysis macro (dipstick) panel - Urine

2964

20097

3.31

197.22

6.7

3.9

—

(3037522) Nuclear Ab [Titer] in Serum

1067

4294

3.08

190.67

1.4

1.3

titre

458.8

528.7

0.72

249

853

(3008898) HLA-B27 [Presence]

502

1223

4.59

190.47

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

165

122

14.10

178.17

3.0

mg/l

6.9

8.1

1.08

132

100

(40760892) CBC W Ordered Manual Differential panel - Blood

1457

7154

2.70

176.83

7.3

4.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

2322

14349

2.64

174.02

6.2

4.5

estimate

0.0

0.50

550

2745

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

157

111

14.72

173.85

2.8

2.6

au/ml

102.7

85.7

0.14

(3009261) Glucose [Presence] in Urine by Test strip

2334

14505

2.63

172.09

4.9

3.3

estimate

0.0

0.00

530

2613

(3035350) Ketones [Presence] in Urine by Test strip

2314

14355

2.61

170.69

4.8

3.3

estimate

0.0

0.80

512

2655

(3017181) Myelocytes/100 leukocytes in Blood

729

2492

3.39

169.58

5.3

4.3

0.6

0.9

2.07

162

685

(3025159) Blasts/100 leukocytes in Blood

680

2235

3.50

168.25

5.5

4.4

0.0

0.4

1.07

143

528

(3021440) Promyelocytes/100 leukocytes in Blood

705

2376

3.43

167.62

5.4

4.3

0.1

2.95

155

633

(3002179) Metamyelocytes/100 leukocytes in Blood

684

2280

3.45

165.34

4.7

4.0

0.3

0.6

3.00

142

499

(3023420) DNA double strand Ab [Units/volume] in Serum

226

321

7.43

151.93

1.3

1.6

iu/ml

25.0

24.9

—

(3021589) Normoblasts [#/volume] in Blood

2150

13465

2.41

146.28

14.7

9.2

e9/l

0.0

2.04

1942

11026

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

296

593

5.34

140.74

3.9

3.6

54.8

57.3

2.76

296

593

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1916

11816

2.28

129.50

2.6

2.2

nmol/l

75.9

75.2

0.48

1803

10834

(3011397) Hemoglobin [Presence] in Urine by Test strip

1227

6524

2.31

115.29

4.7

3.3

—

(40758558) Short blood count panel - Blood

1354

7552

2.24

112.92

9.9

6.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

279

670

4.42

106.17

2.0

1.7

e6/l

8192.1

13498.9

1.45

216

485

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

296

756

4.17

103.83

1.7

1.4

—

(3021788) Differential panel - Synovial fluid

238

518

4.84

102.29

1.8

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

846

4022

2.43

100.87

1.5

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

809

3832

2.42

96.83

3.8

2.4

ug/g

171.6

133.2

2.24

699

3099

(3021879) Hepatitis B virus core Ab [Presence] in Serum

615

2653

2.58

89.42

1.3

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3566

30964

4.47

88.86

22.3

12.9

mg/l

16.5

22.7

37.44

3230

24184

(3018095) Leukocytes [#/volume] in Urine

1562

10030

1.96

82.82

3.9

3.6

e6/l

45.6

89.6

3.08

1084

7081

(3029937) Albumin [Presence] in Urine by Test strip

1261

7650

1.98

77.79

6.0

3.7

estimate

0.0

1.74

538

2629

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

935

5134

2.10

75.81

1.5

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1646

11272

1.82

67.24

5.4

3.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

154

333

4.78

66.48

2.0

1.6

53.2

58.7

0.75

208

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1134

6959

1.90

65.33

2.7

2.1

mg/l

3.0

2.9

1.84

992

5970

(3044941) Cell count panel - Synovial fluid

180

450

4.15

64.61

1.7

1.4

—

(3022145) Colonoscopy Study observation

635

3281

2.13

58.85

1.5

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

122

258

4.85

54.06

1.8

1.5

35.1

30.9

0.53

158

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1855

13708

1.70

53.88

6.4

7.0

mmol/l

1.2

1.48

1576

11645

(3017732) Neutrophils [#/volume] in Blood

454

2125

2.29

53.45

3.7

2.8

e9/l

4.0

4.1

0.10

364

1733

(3000850) Epithelial cells [#/volume] in Urine

953

5906

1.82

51.06

2.6

e6/l

4.1

5.4

3.50

859

5179

(3019150) Specific gravity of Urine by Refractometry

988

6204

1.81

50.60

6.0

3.6

kg/l

1.0

0.65

147

855

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1696

12417

1.67

49.57

5.7

6.2

mmol/l

1.2

2.85

1574

11349

(3024561) Albumin [Mass/volume] in Serum or Plasma

1658

12112

1.66

48.54

5.3

5.1

g/l

36.0

0.00

1561

11327

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

251

946

2.77

46.65

1.6

1.9

—

(40761535) Cells panel - Urine sediment

453

2264

2.14

44.99

5.3

3.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

818

5011

1.81

44.71

1.3

u/ml

15.7

9.7

1.33

343

2061

(3041096) Erythrocytes [Presence] in Urine by Automated

1190

8115

1.69

44.37

4.3

2.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3582

33091

3.09

42.69

21.8

14.6

umol/l

76.2

77.2

0.87

3582

33081

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3588

33237

3.10

41.35

20.3

9.7

u/l

27.4

28.2

1.97

3545

32275

(3031040) Bacteria [#/volume] in Urine by Automated count

2303

18675

1.61

41.31

4.9

4.0

e6/l

229.0

1227.2

1.72

243

(3005719) IgG [Mass/volume] in Serum or Plasma

463

2409

2.05

41.14

2.3

2.7

g/l

11.0

10.6

1.65

431

2204

(3022948) Iron [Moles/volume] in Serum or Plasma

728

4419

1.80

40.57

2.5

umol/l

12.7

13.8

4.25

676

4119

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1731

13184

1.58

40.07

3.3

2.8

ug/l

111.8

127.2

2.55

1637

12354

(36304419) Bacteria [Presence] in Urine

1123

7706

1.65

40.03

3.1

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1132

7800

1.65

39.61

3.3

3.1

e6/l

0.3

0.4

0.25

908

5863

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

832

5284

1.74

39.54

1.3

iu/ml

34.2

30.3

0.22

271

1631

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

262

1108

2.47

38.43

1.3

—

(3018418) pH of Serum or Plasma

1164

8131

1.63

38.29

3.7

4.2

7.4

0.25

230

1591

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3254

29139

1.92

37.97

16.6

11.7

ml/min/173m2

88.9

85.7

15.97

2891

24173

(3045414) Leukocytes [Presence] in Urine

286

1271

2.35

37.56

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

733

4587

1.74

36.35

1.8

1.7

nmol/l

1108.5

1155.1

0.75

566

3564

(3002582) Erythrocytes [#/volume] in Urine

1200

8564

1.59

35.55

3.4

3.2

e6/l

72.5

111.5

0.55

988

6577

(3034891) Synovial lining cells/100 cells in Synovial fluid

133

5.34

35.09

1.6

1.5

3.9

4.4

0.07

(3002385) Erythrocyte distribution width [Ratio]

2979

26179

1.69

34.68

23.5

15.6

13.7

13.6

8.50

2956

25647

(3045424) Erythrocytes [Presence] in Urine

145

476

3.13

34.50

1.4

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

367

1866

2.07

34.46

1.5

1.9

g/l

1.3

1.4

0.55

347

1734

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

187

710

2.72

34.18

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

269

1216

2.31

33.91

1.3

1.2

u/ml

1.3

0.9

0.16

104

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1893

15073

1.52

33.57

5.3

6.2

umol/l

10.2

11.4

3.91

1798

14348

(3027945) Reticulocytes/100 erythrocytes in Blood

505

2907

1.85

32.90

2.2

2.7

1.8

0.64

438

2605

(3004789) Transferrin [Mass/volume] in Serum or Plasma

657

4091

1.74

32.83

2.4

2.5

g/l

2.4

0.20

604

3819

(3010144) Erythrocytes [#/volume] in Synovial fluid

101

272

3.79

32.70

1.8

1.4

e6/l

44367.3

81369.7

0.33

192

(46235355) HIV 1 and 2 tests - Meaningful Use set

934

6419

1.61

31.76

1.7

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

894

6102

1.61

31.19

1.5

g/l

2.8

2.4

5.07

594

3937

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

614

3802

1.74

31.15

2.5

2.6

21.8

23.9

3.15

530

3289

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

722

4744

1.65

29.13

2.6

2.7

e6/l

0.8

1.0

1.41

470

2678

(3023368) Bacteria identified in Blood by Culture

1020

7400

1.52

26.48

4.7

4.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

356

1971

1.89

25.94

1.9

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1080

7968

1.50

25.73

2.6

umol/l

3075.2

3930.6

0.38

955

7050

(3024263) Appearance of Synovial fluid

153

4.24

24.44

2.9

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

196

892

2.26

24.26

1.3

titre

162.1

92.7

0.36

(3004588) Protein electrophoresis panel - Serum or Plasma

315

1728

1.90

23.55

1.8

2.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

366

2112

1.81

23.30

1.9

2.7

g/l

67.8

66.9

1.39

336

1961

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1396

11024

1.43

22.64

2.1

1.9

pmol/l

92.0

96.2

3.09

822

5957

(3023520) Reticulocytes [#/volume] in Blood

364

2131

1.78

22.04

2.3

2.7

e9/l

72.8

71.7

0.21

274

1598

(3032080) INR in Blood by Coagulation assay

1399

11108

1.42

21.76

8.6

inr

1.2

0.45

429

3334

(3021960) Folate [Moles/volume] in Serum or Plasma

837

6049

1.49

21.41

1.6

1.5

nmol/l

20.6

20.1

0.42

735

5283

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1180

9181

1.42

20.23

2.8

2.6

u/l

59.0

57.6

0.24

1101

8549

(40768797) Stomach Pathology biopsy report

593

4046

1.55

19.69

1.2

—

(40761511) CBC panel - Blood by Automated count

3448

32571

1.78

18.98

17.5

11.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

110

432

2.59

18.88

2.5

3.3

1.3

1.5

0.28

347

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

107

418

2.61

18.57

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

231

1251

1.90

17.92

1.5

1.6

u/ml

6.8

15.5

—

(3026782) Osmolality of Urine

753

5500

1.46

17.84

2.9

2.7

mosm/kgh2o

543.9

557.0

0.90

668

4690

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1292

10376

1.38

17.81

3.3

u/l

32.4

34.4

0.51

1229

9886

(3000494) Fungus identified in Specimen by Culture

528

3592

1.55

17.63

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3328

31240

1.61

17.58

16.7

14.4

mmol/l

139.5

139.7

4.40

3272

30509

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

469

3109

1.58

17.55

2.9

4.4

u/l

227.2

242.1

1.81

433

2949

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

927

7082

1.41

17.09

2.9

ng/l

931.8

1192.9

1.72

764

5939

(3007461) Platelets [#/volume] in Blood

3621

34932

2.26

16.20

31.5

18.8

e9/l

267.2

251.6

36.41

3591

34175

(3013826) Glucose [Moles/volume] in Serum or Plasma

1978

17105

1.33

16.19

4.7

4.8

mmol/l

6.5

6.7

2.67

1857

15974

(3023103) Potassium [Moles/volume] in Serum or Plasma

3330

31365

1.58

16.14

16.9

14.5

mmol/l

3.9

4.0

5.08

3265

30575

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

611

4368

1.48

15.99

1.9

1.8

—

(3042936) Bacteria identified in Isolate by Culture

588

4183

1.48

15.76

2.4

2.1

—

(3035941) MCH [Entitic mass]

3621

34961

2.23

15.67

31.3

18.6

30.3

0.48

3609

34565

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

192

1023

1.92

15.66

1.7

1.6

titre

380.0

321.4

0.10

(3024731) MCV [Entitic volume]

3621

34963

2.23

15.63

31.3

18.7

91.4

90.6

20.53

3609

34571

(40761536) Microorganisms panel - Urine sediment

388

2526

1.60

15.61

4.7

3.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1302

10632

1.35

15.58

3.8

3.3

ng/l

82.0

49.4

0.25

841

6662

(3000963) Hemoglobin [Mass/volume] in Blood

3622

34980

2.24

15.57

31.6

18.8

g/l

135.4

138.1

26.48

3608

34577

(3026361) Erythrocytes [#/volume] in Blood

3621

34968

2.23

15.54

31.5

18.7

e12/l

4.5

4.6

26.16

3584

34132

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

239

1371

1.79

15.44

2.0

u/l

38.8

39.3

0.14

217

1235

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

169

868

1.99

15.34

3.1

2.7

—

(3010813) Leukocytes [#/volume] in Blood

3621

34980

2.21

15.32

31.5

18.8

e9/l

7.0

6.7

10.47

3584

34135

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1071

8526

1.36

15.03

2.1

2.2

u/l

162.2

245.6

3.11

1012

8057

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

212

1185

1.84

14.91

1.6

1.8

g/l

1.6

1.5

0.40

174

1034

(3024980) IgG subclass 4 [Mass/volume] in Serum

118

535

2.25

14.83

1.6

g/l

0.6

0.8

1.35

411

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

884

6839

1.38

14.80

1.3

u/ml

1.2

1.7

0.88

223

1857

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

173

913

1.94

14.53

1.6

1.7

g/l

0.2

0.15

162

866

(3044640) Blood type and Crossmatch panel - Blood

1133

9143

1.34

14.42

2.5

2.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

479

3325

1.51

14.40

20.0

21.8

inr

1.3

0.59

495

(3015377) Calcium [Moles/volume] in Serum or Plasma

1145

9265

1.34

14.28

2.9

3.4

mmol/l

2.3

0.36

1016

8270

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

276

2.72

14.15

1.3

titre

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

271

2.73

14.09

1.1

1.2

u/l

52.2

64.0

0.88

188

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1625

13849

1.31

13.92

4.0

3.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

494

3491

1.48

13.56

2.0

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

874

6842

1.36

13.40

1.9

1.7

mg/l

1.0

1.1

0.44

655

5113

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

753

5759

1.39

13.34

1.7

1.6

pmol/l

45161708.1

34479676.2

0.15

651

4916

(3004616) Nuclear Ab [Presence] in Serum

351

2.45

13.24

1.2

—

(3019225) pH of Specimen

387

2612

1.54

13.24

4.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

174

950

1.87

13.21

1.6

1.7

g/l

1.2

0.33

166

901

(3017354) Segmented neutrophils/100 leukocytes in Blood

264

2.68

13.13

2.4

3.4

58.4

55.9

0.38

178

(40768443) Skin Pathology biopsy report

209

1211

1.77

13.06

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

288

1824

1.63

12.94

1.3

1.2

—

(3026008) Bacteria identified in Urine by Culture

927

7370

1.34

12.75

3.1

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

884

6982

1.35

12.69

2.5

2.3

—

(40768804) Tissue Pathology biopsy report

1420

12027

1.29

12.25

2.1

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

293

2.52

12.11

2.2

4.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

959

1.82

11.94

1.7

2.4

g/l

4.0

3.8

0.83

124

709

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

959

1.82

11.94

1.7

2.4

g/l

7.3

0.10

127

743

(3009871) Measles virus Ab [Titer] in Serum

125

3.39

11.90

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

170

959

1.81

11.65

1.7

2.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

907

1.82

11.39

1.6

2.4

g/l

3.2

3.1

0.83

126

724

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

138

734

1.91

11.39

1.6

2.4

g/l

0.0

1.43

126

690

(3022621) pH of Urine by Test strip

276

1792

1.58

11.19

3.4

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

110

544

2.05

11.17

1.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

111

3.45

11.10

1.1

1.0

—

(3013512) EKG study

960

7835

1.30

10.66

3.8

3.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

149

831

1.83

10.63

1.6

2.5

g/l

0.7

1.0

0.40

132

740

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

150

841

1.82

10.52

1.9

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2972

27897

1.32

10.32

4.5

mu/l

1.8

2.1

2.23

2769

25929

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

188

1132

1.70

10.30

2.2

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

370

2.22

10.11

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

252

2.49

10.08

1.3

1.2

titre

303.8

138.1

0.67

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

172

1021

1.72

9.93

2.0

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

110

569

1.96

9.90

1.9

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2523

23242

1.26

9.82

3.8

pmol/l

14.9

14.6

5.50

2324

21462

(3036481) Cortisol [Moles/volume] in Serum or Plasma

396

2848

1.44

9.81

2.2

nmol/l

336.5

366.8

2.23

365

2646

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

115

607

1.92

9.76

1.7

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

114

600

1.93

9.76

1.3

1.2

u/ml

9.1

3.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

146

837

1.77

9.54

1.3

1.2

u/ml

33.9

45.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

223

2.53

9.52

1.2

1.1

—

70.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

579

4462

1.35

9.50

3.0

2.9

e6/l

2.6

2.1

0.57

329

2410

(4062490)

330

2.24

9.37

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

152

888

1.74

9.31

1.8

2.4

g/l

11.1

10.3

0.96

134

771

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

137

777

1.79

9.29

1.3

1.2

u/ml

3.4

7.3

1.04

115

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

283

1930

1.50

9.20

3.8

4.2

ng/l

86.9

89.3

0.13

252

1720

(3037756) Immunofixation for Serum or Plasma

487

2.00

9.16

1.3

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

148

863

1.74

9.13

1.9

2.1

mg/l

10.4

11.1

0.48

137

804

(3014051) Protein [Presence] in Urine by Test strip

116

630

1.87

9.05

2.3

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

134

766

1.78

8.86

1.3

1.2

u/ml

3.0

2.8

0.06

(3024139) IgG subclass 3 [Mass/volume] in Serum

327

2.19

8.74

1.3

g/l

0.4

0.02

226

(3027135) IgG subclass 1 [Mass/volume] in Serum

328

2.19

8.68

1.3

g/l

6.7

6.8

0.11

229

(3028192) IgG subclass 2 [Mass/volume] in Serum

328

2.19

8.68

1.3

g/l

3.5

3.0

1.38

229

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

131

751

1.77

8.59

1.6

2.3

g/l

38.1

38.0

0.05

116

668

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

455

3432

1.37

8.52

2.7

2.9

umol/l

8.0

7.8

0.05

397

2993

(3049717) Cytology report of Urine Cyto stain

165

1012

1.66

8.48

2.7

2.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

128

732

1.78

8.47

2.2

3.7

ratio

1.3

2.5

0.77

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

402

2983

1.39

8.32

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

121

687

1.79

8.22

1.7

2.4

g/l

0.0

0.00

109

643

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

244

1654

1.51

8.18

3.9

3.5

mmol/l

2.0

1.7

0.62

180

1236

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

369

2711

1.40

8.10

2.4

2.3

g/l

0.2

0.10

339

2542

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

305

2.18

8.09

2.7

2.2

mg/l

23.7

21.2

0.13

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

171

1076

1.62

7.96

4.6

3.7

mmol/l

25.1

24.8

0.89

161

1004

(3030981) Hyaline casts [#/volume] in Urine by Automated count

212

1409

1.54

7.80

2.8

e6/l

0.4

0.3

0.54

203

1369

(36660697) Celiac disease serology panel - Serum

339

2471

1.41

7.79

1.2

—

(3022313) Gas panel - Capillary blood

193

1257

1.56

7.78

4.4

3.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

225

1516

1.52

7.77

1.7

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2376

21981

1.22

7.77

3.2

3.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

128

753

1.72

7.71

2.2

3.7

mg/l

28.9

64.8

1.29

606

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.54

7.68

1.6

1.3

41.5

33.2

0.44

(3005011) Chlamydia sp Ab [Titer] in Serum

4.34

7.67

1.6

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.44

7.66

1.2

g/l

43.5

37.7

0.91

(3026470) Cobalt [Mass/volume] in Blood

164

2.58

7.50

2.0

ug/l

2.9

3.0

0.06

142

(3034860) Kappa light chains.free [Mass/volume] in Serum

127

752

1.71

7.48

2.2

3.7

mg/l

43.8

63.0

1.02

605

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

225

2.33

7.47

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

225

2.33

7.47

1.1

1.0

—

(3009343) pH of Capillary blood

248

1725

1.47

7.34

4.1

3.5

7.4

0.41

222

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

117

681

1.74

7.34

1.7

2.4

g/l

0.0

0.00

108

642

(3011412) CD3 cells [#/volume] in Blood

306

2.11

7.24

1.8

2.7

e9/l

1.0

1.2

0.88

179

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

150

2.62

7.19

1.1

u/l

25.0

17.2

0.28

126

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

753

6224

1.26

7.19

1.7

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

156

2.58

7.18

1.1

u/l

91.7

86.3

0.11

134

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

398

3021

1.36

7.14

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

336

2.04

7.06

1.9

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

249

1747

1.46

7.06

4.1

3.5

kpa

5.3

5.2

1.04

234

1621

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

316

2.08

7.05

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

163

1046

1.58

7.03

1.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

337

2.04

7.01

1.9

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

337

2.04

7.01

1.9

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

344

2.02

7.00

1.9

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

338

2.03

6.95

1.9

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

166

1077

1.57

6.84

2.1

ug/l

1.0

1.8

1.58

149

975

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

172

2.46

6.83

1.6

1.5

u/l

4.7

6.2

0.26

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

327

2.04

6.82

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

216

2.29

6.78

1.2

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

595

4823

1.28

6.63

2.7

3.0

mmol/l

2.4

0.04

520

4236

(3042631) Mycobacterium sp identified in Specimen

360

1.96

6.53

2.7

2.6

—

(3044927) Protein electrophoresis panel - Urine

252

2.16

6.53

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

466

3670

1.31

6.48

5.7

6.6

mmol/l

1.0

0.16

435

3452

(3025577) Chromium [Mass/volume] in Blood

159

2.47

6.42

2.1

ug/l

1.8

2.1

0.26

137

(3024522) Salmonella sp identified in Specimen by Organism specific culture

342

1.98

6.40

1.9

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

892

7603

1.23

6.36

4.1

4.0

93.1

91.8

0.90

861

7425

(3014765) Yersinia sp identified in Stool by Organism specific culture

142

905

1.59

6.34

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

242

2.17

6.34

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

296

2186

1.38

6.32

2.5

2.4

au/ml

28.8

20.1

0.70

142

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

141

900

1.59

6.26

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

135

854

1.60

6.23

2.7

3.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

138

2.55

6.19

1.1

u/l

64.9

83.3

1.39

107

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

138

2.55

6.19

1.1

u/l

13.2

22.4

1.46

100

(42529406) Shigella sp [Presence] in Stool by Culture

142

911

1.58

6.18

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.60

6.03

1.4

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

299

2239

1.36

5.87

3.4

3.9

mmol/l

1.2

0.73

270

1960

(3005322) IgE [Units/volume] in Serum or Plasma

278

2059

1.38

5.84

1.4

1.3

u/ml

231.6

227.3

0.01

264

1906

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

100

600

1.69

5.70

1.5

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

423

1.81

5.63

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

515

4187

1.27

5.57

1.9

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

229

2.11

5.54

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

229

2.11

5.54

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

229

2.11

5.54

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3055

29324

1.23

5.53

21.0

13.6

40.0

40.7

5.26

2208

22637

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

232

2.08

5.37

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

232

2.08

5.37

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

232

2.08

5.37

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

316

4074

0.75

5.35

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.55

5.32

1.1

1.5

nmol/l

7.4

718927.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

466

3764

1.27

5.32

1.8

2.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.63

5.25

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

161

1106

1.48

5.17

1.3

miu/ml

182.0

214.5

0.53

516

(1761868) Lipid panel - Serum or Plasma

1105

12408

0.84

5.15

2.5

2.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

195

1392

1.42

5.11

2.4

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

115

737

1.58

5.09

1.5

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

421

3382

1.28

5.02

4.2

32.3

31.2

1.45

322

2407

(3014576) Chloride [Moles/volume] in Serum or Plasma

438

3545

1.27

4.91

7.0

7.5

mmol/l

103.8

104.5

2.43

430

3471

(3001729) Color of Synovial fluid

4.59

4.78

2.2

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

272

3521

0.75

4.74

1.6

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

198

2.08

4.64

1.6

1.5

u/l

4.6

7.9

2.45

167

(21494815) CD4 cells/100 lymphocytes in Specimen

288

1.89

4.64

1.9

2.5

46.7

43.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

2.27

4.63

1.0

1.1

miu/ml

1386.2

1461.0

0.16

146

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

115

2.45

4.62

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

458

1.70

4.61

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

219

2.02

4.60

1.9

2.9

e6/l

485.7

562.3

0.38

189

(3016502) Oxygen saturation in Arterial blood

356

2835

1.28

4.56

6.9

8.7

95.1

95.9

1.10

340

2740

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

220

2.01

4.55

1.5

2.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

392

3168

1.27

4.46

6.6

8.2

kpa

5.2

5.1

0.90

370

3039

(3037121) Protein [Mass/volume] in Urine

142

983

1.46

4.43

3.4

g/l

0.4

0.3

0.42

436

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

209

2.02

4.41

2.0

3.0

e9/l

0.2

0.31

186

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

306

2404

1.30

4.36

2.6

2.5

ml/min/173m2

70.2

70.5

0.05

118

886

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

217

1.99

4.35

1.6

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

391

3169

1.26

4.34

6.6

8.2

kpa

12.5

12.6

0.13

368

3040

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

272

0.29

4.23

5.5

18.6

nmol/l

1566.9

1453.3

—

265

(3016650) Hepatitis A virus Ab [Presence] in Serum

579

1.59

4.22

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

262

1.88

4.21

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

262

1.88

4.21

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

262

1.88

4.21

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

220

1.97

4.20

1.6

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

629

5394

1.20

4.07

3.7

3.5

ng/l

655.5

481.6

0.23

441

3917

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

238

1.90

4.01

1.7

2.2

14.6

14.0

0.11

100

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

349

2819

1.26

4.00

2.7

2.5

u/l

135.2

54.0

0.38

298

2456

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

447

1.65

3.97

1.3

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.43

3.96

1.6

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

157

2.11

3.93

2.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

191

2.00

3.92

2.7

2.2

—

(3000330) Specific gravity of Urine by Test strip

176

1299

1.37

3.87

2.9

3.1

—

(3003396) Base excess in Arterial blood by calculation

385

3161

1.24

3.84

6.7

8.2

mmol/l

1.0

0.10

297

2455

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

578

1.55

3.81

1.6

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

102

683

1.51

3.80

2.6

6.3

iu/ml

543.6

826.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

408

1.65

3.74

1.3

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

487

1.59

3.70

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

142

2.12

3.64

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

577

1.54

3.63

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

104

709

1.48

3.58

1.6

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

117

2.23

3.57

4.2

3.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

157

2.05

3.55

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

157

2.05

3.55

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

157

2.05

3.55

2.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

236

1.83

3.47

1.2

1.1

—

27.2

—

(3019060) Gas panel - Arterial blood

231

1808

1.30

3.44

4.4

5.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

133

2.11

3.39

1.8

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

491

1.56

3.37

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

190

1453

1.32

3.36

8.2

10.8

mmol/l

24.8

24.3

1.14

174

1376

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

468

1.57

3.35

1.1

g/l

1.5

0.41

425

(3018677) aPTT in Platelet poor plasma by Coagulation assay

512

4389

1.19

3.32

2.1

30.0

29.8

0.36

494

4258

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

391

1.62

3.31

1.3

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.42

3.30

1.3

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

213

1661

1.30

3.28

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

100

690

1.46

3.27

1.6

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

544

4698

1.18

3.24

2.9

3.5

mmol/l

0.8

0.77

510

4438

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

183

2368

0.76

3.24

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

635

1.48

3.21

1.4

1.2

u/ml

38.5

44.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

206

1.85

3.21

2.0

1.9

u/field

1.2

1.9

0.43

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

261

2100

1.26

3.14

2.7

2.8

ng/l

147.9

172.5

0.56

236

1885

(3028433) Virus identified in Specimen by Culture

2.23

3.05

1.5

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

309

2548

1.23

3.00

6.9

8.3

mmol/l

9.0

9.2

0.24

292

2445

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

209

1648

1.28

2.98

1.6

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

2.16

2.96

2.2

3.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

517

1.50

2.91

1.3

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

133

989

1.36

2.88

3.8

4.2

mmol/l

1.4

0.04

126

977

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

206

1630

1.28

2.87

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

593

1.46

2.86

1.5

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

363

1.58

2.75

1.8

2.0

umol/l

6.5

6.6

0.02

255

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

516

1.48

2.75

1.7

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

210

1.77

2.74

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1141

10508

1.12

2.72

4.5

4.3

ug/l

3.6

2.4

0.81

1023

9538

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

132

1.98

2.70

1.3

1.1

—

(3044889) 12 lead EKG panel

2209

21106

1.11

2.69

3.6

3.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

115

847

1.37

2.67

3.8

4.4

mmol/l

3.9

0.16

108

799

(3028679) Herpes simplex virus Ab [Presence] in Serum

192

1.78

2.58

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

542

1.45

2.53

3.8

3.7

u/ml

462.0

807.3

0.28

502

(1616796) Gas panel - Central venous blood

626

1.42

2.52

3.2

3.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

129

977

1.33

2.52

1.9

2.4

ug/l

412.8

474.3

0.11

114

919

(3023410) Appearance of Cerebral spinal fluid

324

1.58

2.51

1.5

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

296

2479

1.21

2.51

6.8

7.7

mmol/l

1.4

0.23

283

2388

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

398

3426

1.18

2.49

7.1

6.4

—

(3020891) Body temperature

144

1113

1.31

2.45

4.5

4.8

—

(4034850)

130

991

1.32

2.44

13.7

8.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

514

1.45

2.42

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

142

1098

1.30

2.41

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.35

2.38

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

527

1.43

2.32

2.7

3.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

355

1.53

2.32

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

126

1.91

2.30

2.5

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

511

4517

1.15

2.29

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

142

1.84

2.23

1.5

1.3

—

68.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

729

1.35

2.19

1.5

e6/l

6737.7

1260.1

0.44

587

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

729

1.35

2.19

1.4

e6/l

72.8

21.1

0.51

557

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

120

921

1.31

2.18

2.4

2.6

g/l

3.9

3.6

1.24

113

872

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

136

1.84

2.17

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

101

1.99

2.15

1.0

1.6

—

(3021901) Oxygen saturation in Capillary blood

494

1.42

2.14

1.8

2.7

—

(3017704) Immunofixation for Urine

144

1.81

2.14

1.2

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

159

1975

0.80

2.12

1.5

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

2.37

2.12

2.4

2.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

152

1.78

2.11

1.7

u/field

1.0

4.1

1.48

114

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.20

2.09

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

138

1.82

2.09

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2876

28028

1.11

2.07

5.2

mmol/mol

38.0

39.3

11.81

2715

26339

(3029075) Extractable nuclear Ab panel - Serum

2.08

2.06

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

125

1.85

2.02

2.6

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

125

1.85

2.02

2.6

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3026

29587

1.12

2.01

4.3

4.2

mmol/l

5.8

5.9

2.31

2803

27427

(40768441) Liver Pathology biopsy report

224

1.61

1.99

1.1

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.29

1.97

1.6

1.2

ug/l

2.1

72.7

—

(4010399)

243

2051

1.20

1.95

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

560

0.64

1.95

1.1

iu/ml

15.3

1013.3

—

138

(3000570) Elastase.pancreatic [Mass/mass] in Stool

107

824

1.31

1.93

1.3

1.4

ug/g

258.8

290.2

0.75

469

(3010421) pH of Blood

101

772

1.32

1.92

3.8

4.4

7.4

0.70

643

(3000012) Reticulocyte production index

135

1.78

1.91

1.5

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

337

2933

1.16

1.89

4.1

3.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

119

933

1.28

1.89

1.5

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

157

0.38

1.88

2.5

2.2

nmol/l

112.7

155.5

—

135

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

212

1.61

1.88

1.4

1.2

ratio

1.2

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

151

1.73

1.86

2.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

101

1.89

1.80

1.2

1.3

—

(3048879) Bone marrow aspiration report

2.06

1.80

1.7

2.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

123

1.79

1.9

1.7

umol/l

2.1

2.0

0.29

116

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

267

2294

1.18

1.77

2.7

2.3

ug/l

5.3

8.1

1.72

228

2067

(3008295) Osmolality of Serum or Plasma

304

1.49

1.77

1.4

mosm/kgh2o

278.5

282.3

0.48

235

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

730

1.31

1.77

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

3.34

1.74

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

147

1.71

1.73

2.3

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

2.67

1.72

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.92

1.72

1.0

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.85

1.71

1.0

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

304

2648

1.16

1.71

7.9

9.1

g/l

120.2

123.8

2.48

295

2555

(3022689) Creatine [Moles/volume] in Urine

1.93

1.64

1.4

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

220

1874

1.18

1.64

2.5

3.4

pmol/l

4.6

4.5

0.17

193

1684

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

704

1.30

1.64

1.3

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

253

2181

1.17

1.63

1.1

1.2

iu/ml

82.9

151.1

3.01

822

(3023419) Bacteria identified in Sputum by Culture

352

1.43

1.62

2.7

2.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2283

22120

1.08

1.60

3.3

3.1

u/l

50.8

47.4

0.99

2159

20947

(3022493) Free Hemoglobin [Mass/volume] in Plasma

113

1.77

1.60

1.8

5.1

mg/l

71.8

62.7

0.27

(3012501) Base excess in Blood by calculation

654

1.31

1.60

4.1

4.4

mmol/l

3.1

2.3

1.14

441

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

238

1.52

1.59

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

1.59

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.00

1.58

1.2

1.6

umol/24h

196.5

366.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

204

1734

1.19

1.57

6.8

7.6

mmol/l

25.0

24.5

1.19

187

1623

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

508

1.34

1.57

1.3

1.4

u/l

22.6

26.0

0.46

419

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

256

1.49

1.55

2.2

2.8

e6/l

898.6

699.7

0.79

103

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

562

1.32

1.53

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

562

1.32

1.53

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

265

1.48

1.53

1.9

2.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.28

1.53

1.7

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

336

2982

1.14

1.48

2.1

2.3

nmol/l

13.5

13.4

0.07

291

2685

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.44

1.47

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

558

0.70

1.47

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

211

1.52

1.45

1.1

u/l

1.5

1.1

0.59

105

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

1.77

1.44

1.7

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.97

1.43

1.1

1.4

—

(44806071)

2.31

1.43

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

795

0.75

1.42

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

221

1.50

1.40

1.3

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

423

0.66

1.40

1.4

1.3

mmol/l

7.3

7.1

0.11

313

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

712

1.27

1.40

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

165

1.58

1.40

1.6

iu/ml

—

1357434.6

—

(3009508) Creatinine [Moles/volume] in Urine

960

9032

1.08

1.39

3.3

mmol/l

8.1

0.19

833

7738

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.08

1.38

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

280

1.43

1.38

1.7

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

608

1.29

1.37

2.0

2.2

g/l

132.9

132.1

0.10

448

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

408

3686

1.12

1.37

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

142

1186

1.21

1.36

2.1

2.3

u/l

4058.2

4498.8

0.07

453

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

734

1.26

1.35

1.2

1.3

mmol/l

3.4

3.8

5.58

683

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

109

887

1.24

1.35

1.1

u/ml

2.5

4.3

—

124

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

108

878

1.24

1.35

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.15

1.33

1.0

—

(3006270) Folate [Moles/volume] in Blood

224

1.48

1.33

1.2

1.1

nmol/l

348.1

376.7

0.36

204

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

671

0.74

1.31

1.3

1.5

—

(3000492) Spirometry study

365

3286

1.12

1.31

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.74

1.30

2.0

1.4

ug/l

8.3

8.6

0.14

(3051593) INR in Capillary blood by Coagulation assay

1.74

1.30

15.1

11.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

326

1.39

1.30

1.3

1.8

—

(3012516) Albumin [Mass/volume] in Urine

870

8176

1.08

1.29

3.2

3.3

mg/l

770.0

344.8

1.21

558

5327

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

111

1347

0.82

1.29

2.0

1.7

mg/l

5.1

4.1

0.26

937

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

713

1.25

1.27

1.3

1.4

—

23.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

405

1.34

1.26

1.3

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

337

1.37

1.25

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

659

6132

1.09

1.24

2.8

2.7

ug/l

0.7

1.01

453

3696

(3015235) Bicarbonate [Moles/volume] in Capillary blood

698

1.25

1.24

2.6

3.2

mmol/l

25.5

24.8

0.68

612

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

338

1.37

1.23

2.3

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.63

1.21

1.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

116

1.64

1.21

1.0

1.2

—

(3006462) Nitrate [Presence] in Urine

116

1.64

1.21

4.5

3.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

148

1.56

1.20

1.3

1.7

nmol/l

2.6

7.2

0.75

121

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

148

1.56

1.20

1.0

1.1

iu/ml

138.2

195.2

1.08

148

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

306

1.38

1.19

2.4

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

291

2602

1.13

1.19

3.4

4.3

ug/l

131.6

20.3

0.88

229

2097

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

281

1.39

1.18

1.1

mg/l

300.3

281.2

0.09

238

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.50

1.15

1.0

5.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

608

1.26

1.13

2.2

3.1

kpa

8.2

0.03

558

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

159

1.51

1.11

1.3

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

159

1.51

1.11

1.3

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

105

874

1.21

1.09

3.5

3.1

u/ml

0.3

0.03

479

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

269

1.38

1.08

2.6

2.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

648

1.24

1.08

1.3

1.5

u/ml

92.8

118.0

1.94

127

(3019174) dRVVT (LA screen)

2.19

1.08

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

177

1.47

1.07

1.3

1.4

nmol/l

149.7

133.5

0.98

177

(4211845)

129

1.55

1.05

4.3

3.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

237

1.40

1.04

1.4

1.2

u/ml

0.2

0.8

0.79

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.96

1.03

23.0

9.6

mmol/l

4.5

6.3

—

(3000991) Gas panel - Venous blood

260

2333

1.12

1.03

8.6

9.3

—

(3002256) Pathology report gross observation

410

3770

1.10

1.03

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

671

1.23

1.02

1.3

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.00

1.00

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.00

1.00

1.0

1.1

—

(3034426) Prothrombin time (PT)

131

1.53

0.99

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

115

1.57

0.99

2.7

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

115

1.57

0.99

2.7

1.5

—

(3025315) Body weight

2.18

0.98

2.8

3.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

292

1.34

0.97

1.2

mg/l

31.4

42.1

2.45

235

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

140

1.50

0.97

1.1

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

140

1.50

0.97

1.1

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.97

0.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.80

0.96

1.0

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

116

1.55

0.96

1.4

1.2

g/l

0.3

0.85

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

879

8361

1.07

0.95

3.9

3.8

21.3

21.5

0.20

431

3592

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

259

1.35

0.94

4.1

4.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.22

0.93

1.5

1.0

—

(3012441) Differential panel - Pleural fluid

243

1.36

0.92

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.91

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

1.42

0.90

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.60

0.90

1.1

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

508

0.77

0.90

4.2

2.4

13.2

13.1

0.53

503

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

692

1.20

0.89

1.2

u/ml

298.8

267.1

0.43

440

(3047007) Chlamydophila sp Ab [Presence] in Serum

494

1.24

0.87

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

144

1.46

0.87

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

352

1.28

0.85

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.85

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.85

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.85

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.85

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

111

957

1.16

0.83

1.9

pmol/l

208.8

209.5

0.03

106

908

(3020191) Ethanol [Moles/volume] in Serum or Plasma

296

0.71

0.82

1.4

1.5

promille

1.1

1.4

0.42

227

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.65

0.81

1.3

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.58

0.81

1.6

2.1

ug/l

80.6

56.1

0.53

(3028308) Erythrocytes [#/volume] in Pleural fluid

250

1.32

0.80

1.4

e6/l

44551.4

97579.1

0.83

149

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3136

31019

1.07

0.79

4.3

4.1

mmol/l

4.7

1.68

2961

29234

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.73

0.79

1.3

1.1

umol/24h

0.8

0.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

240

2183

1.11

0.79

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

259

1.32

0.79

3.7

3.1

mg/l

177.3

70.3

0.35

192

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.82

0.79

1.2

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.67

0.78

1.6

1.8

pmol/l

24.1

28.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

216

1.35

0.78

2.1

2.9

44.1

39.2

0.66

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.78

0.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

704

1.18

0.77

1.3

1.4

—

(3014891) Appearance of Pleural fluid

1.77

0.76

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

261

1.31

0.76

1.6

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.76

0.0

1.3

—

22.6

—

(4212803)

2.08

0.74

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

169

1515

1.12

0.74

9.4

11.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

201

1.35

0.74

1.2

1.1

iu/ml

17.9

10.1

—

(4027681)

228

1.32

0.72

1.2

1.3

—

(3036603) Volume of Urine

202

1.34

0.72

2.2

1.4

1352.2

2053.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.61

0.72

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.52

0.72

1.2

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.62

0.71

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.71

1.6

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.92

0.70

1.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

329

3536

0.92

0.70

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3172

31417

1.06

0.70

4.6

4.5

mmol/l

2.8

2.67

2980

29445

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

1.35

0.70

1.4

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

283

1.27

0.69

1.6

1.4

e6/l

1802.9

2391.3

0.42

204

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.53

0.68

3.0

3.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

122

1079

1.14

0.68

1.3

1.4

u/l

8.1

8.8

0.28

101

880

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

854

1.15

0.67

2.6

3.3

mg/l

1.4

1.5

0.18

791

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

180

0.67

1.0

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

603

1.18

0.67

2.1

2.4

16.9

16.6

0.17

302

(40765096) Chromosome analysis panel by Banding

0.55

0.67

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.79

0.66

1.0

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

167

0.66

50.1

34.9

ug/l

6.6

7.5

0.79

152

(21494434) Karyotype in Bone marrow

241

1.29

0.65

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

202

0.69

0.65

1.9

1.6

mmol/l

8.2

7.7

—

121

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

277

1.27

0.65

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.64

1.2

2.7

u/field

0.2

0.7

—

(3042733) HLA Ab [Presence] in Serum

129

0.62

0.63

5.1

5.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

826

7942

1.05

0.63

1.6

mmol/l

1.4

0.28

709

6751

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

130

1162

1.12

0.63

4.7

3.9

51.7

49.9

0.36

130

1145

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

1.41

0.62

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

104

0.58

0.61

1.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

189

1727

1.10

0.61

1.8

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

343

1.23

0.61

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.5

—

20.3

—

(3024928) Oxygen saturation in Venous blood

629

0.84

0.60

5.0

3.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

245

1.27

0.59

1.4

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3112

30840

1.05

0.59

4.2

4.1

mmol/l

1.4

1.58

2921

28939

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

110

978

1.13

0.59

1.6

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

124

1111

1.12

0.59

5.5

5.7

1.7

0.10

118

1038

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.58

0.0

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

886

8553

1.05

0.58

4.0

4.1

mg/mmol

13.1

9.1

1.22

586

5611

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

548

1.17

0.58

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

373

1.21

0.57

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

106

1.42

0.57

4.9

2.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

207

0.72

0.56

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.67

0.56

3.7

5.4

—

(3004451) EKG impression Narrative

141

1.35

0.56

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.51

0.56

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

550

1.17

0.56

1.3

1.2

u/ml

2.7

4.3

0.45

178

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

185

1.30

0.56

1.0

ng/l

37.5

42.2

0.34

120

(3033799) Differential panel - Peritoneal fluid

0.56

2.8

2.2

—

(3012898) Urea [Moles/volume] in Urine

1.62

0.55

1.2

1.6

mmol/l

249.2

168.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.62

0.55

1.7

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

251

0.76

0.55

1.1

—

(44790048)

340

1.21

0.53

1.3

1.6

—

(44790049)

340

1.21

0.53

1.3

1.6

—

(44790047)

340

1.21

0.53

1.3

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

340

1.21

0.53

1.0

1.1

—

(44806118)

340

1.21

0.53

1.3

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.54

0.53

2.7

2.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

136

0.66

0.51

5.1

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

136

0.66

0.51

2.6

3.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

109

1.38

0.50

2.3

2.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

352

1.20

0.50

1.3

nmol/l

—

(3042517) Benzodiazepines panel - Urine

1.46

0.50

1.5

2.7

—

(4024509)

225

1.25

0.49

1.4

—

(3003694) ABO and Rh group [Type] in Blood

898

8707

1.04

0.49

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.56

0.49

1.1

3.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.52

0.48

2.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.52

0.48

1.1

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

212

1975

1.08

0.48

1.2

—

(4281824)

266

0.79

0.46

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

523

1.15

0.46

1.1

119.3

114.8

0.70

483

(3050129) First trimester maternal screen panel - Serum or Plasma

101

911

1.11

0.46

1.3

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

182

1.27

0.46

1.0

ng/l

893.8

766.0

0.43

122

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.61

0.45

1.8

1.5

g/l

12.2

12.0

—

(4035726)

263

2479

1.07

0.44

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

662

0.87

0.44

2.2

nmol/l

0.7

0.8

0.74

561

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.45

0.44

1.1

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

184

1.25

0.43

1.0

ng/l

282.2

290.7

0.08

125

(1001926) Buprenorphine [Presence] in Urine by Screen method

136

1252

1.09

0.42

2.4

2.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

229

0.78

0.42

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.63

0.42

1.8

1.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.38

0.41

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.38

0.41

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.38

0.41

1.0

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

294

0.82

0.41

2.9

2.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.4

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.41

0.0

1.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.7

—

496.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

1.33

0.41

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

213

1.22

0.40

1.3

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.47

0.40

1.6

1.2

umol/24h

2.2

1.8

—

(40768806) Pleura Pathology biopsy report

250

1.20

0.40

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

112

1027

1.09

0.39

1.5

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

144

1336

1.08

0.39

2.7

3.0

u/ml

52.8

46.7

0.19

138

1292

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.39

0.0

1.3

—

22.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

187

1.23

0.39

1.5

1.2

—

(3020491) Glucose [Moles/volume] in Blood

233

1.20

0.38

1.6

1.8

mmol/l

7.2

6.9

0.30

154

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.39

0.38

3.2

1.5

—

(3036489) Thrombin time

129

1193

1.08

0.38

2.2

2.1

21.2

21.3

0.03

109

1032

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.34

0.38

1.2

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

181

0.77

0.38

1.6

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

129

1391

0.92

0.37

1.5

—

(1002224) Polysomnography panel

176

1651

1.07

0.36

1.0

1.1

—

(4015189)

1.29

0.36

3.3

2.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

253

1.19

0.36

1.4

1.5

umol/l

11.1

12.0

0.62

237

(3027944) Amphetamines [Presence] in Urine

168

1574

1.07

0.36

2.1

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

337

3226

1.05

0.35

1.6

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.65

0.35

1.8

2.1

umol/l

9.8

15.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

212

0.80

0.35

2.4

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

406

0.86

0.35

1.3

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

119

1102

1.08

0.35

5.6

5.8

0.9

0.35

112

1032

(3024932) HLA-DR beta [Type]

125

0.72

0.35

1.4

1.1

—

(3024471) HLA-A [Type]

125

0.72

0.35

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.40

0.35

1.5

1.3

—

(3045142) Bone marrow Pathology biopsy report

320

1.16

0.34

1.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

490

1.12

0.34

1.1

u/ml

2.1

2.4

0.16

249

(3023183) Ammonium ion [Moles/volume] in Plasma

652

1.11

0.34

2.3

3.1

umol/l

33.5

36.6

0.56

572

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.33

0.33

1.2

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

1.30

0.33

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

166

0.78

0.33

1.5

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

539

1.12

0.33

1.2

u/ml

3.5

4.8

0.59

241

(3027923) C peptide [Moles/volume] in Serum or Plasma

187

0.80

0.32

1.8

1.4

nmol/l

1.4

1.3

—

145

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.33

0.32

1.1

u/ml

0.1

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

147

1.23

0.30

3.3

2.5

umol/l

139.3

173.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.30

0.30

1.1

1.3

—

(3027008) Opiates [Presence] in Urine

170

1607

1.06

0.30

2.3

2.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.27

0.30

1.4

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.27

0.30

1.4

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

169

1598

1.06

0.30

2.3

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

102

1.28

0.30

1.7

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

196

0.82

0.30

2.1

1.9

—

(3035285) Chloride [Moles/volume] in Venous blood

303

0.86

0.29

2.7

2.5

mmol/l

105.9

105.6

0.15

296

(3041354) Potassium [Moles/volume] in Venous blood

303

0.86

0.29

2.7

2.5

mmol/l

4.1

4.0

0.25

296

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

130

0.77

0.29

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

535

0.90

0.29

1.4

nmol/l

0.2

0.4

1.90

421

(3035637) Corticotropin [Mass/volume] in Plasma

373

1.13

0.29

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

298

1.14

0.28

2.9

5.9

mmol/l

7.2

7.4

0.10

251

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

140

0.79

0.28

1.3

umol/l

3.1

4.9

0.78

134

(3020650) Glucose [Presence] in Urine

1.32

0.28

1.2

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.29

0.28

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

170

1613

1.06

0.27

2.3

2.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

109

1164

0.93

0.27

1.6

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

104

1.25

0.26

1.1

2.1

203.0

158.4

0.53

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

760

1.08

0.26

1.5

1.9

iu/l

3.6

4.8

0.77

291

(3043238) Trisomy 21 risk [Likelihood] in Fetus

635

0.91

0.26

1.6

1.5

—

(3012544) pH of Venous blood

271

2607

1.04

0.26

4.3

3.9

—

7.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

1.18

0.25

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

396

1.11

0.25

2.1

1.7

—

(44813793)

216

1.16

0.25

1.2

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

133

1258

1.06

0.25

3.5

2.8

0.7

0.59

124

1209

(3044242) Glucose [Moles/volume] in Arterial blood

142

1.20

0.24

3.2

2.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

135

1279

1.06

0.24

1.5

1.6

mu/l

275.3

291.7

0.20

121

1163

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

369

1.11

0.24

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.71

0.24

1.5

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.71

0.24

1.5

2.9

—

(3002032) Base excess in Venous blood by calculation

261

2517

1.04

0.23

4.3

4.0

mmol/l

1.9

0.01

215

2048

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

495

0.91

0.23

1.4

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

109

1028

1.06

0.23

2.4

2.2

92.9

92.5

0.06

103

962

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

0.80

0.23

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.28

0.23

1.0

1.9

ng/l

60.0

139.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

232

0.86

0.22

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

125

1.20

0.22

2.0

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.22

0.22

1.4

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.19

0.21

1.2

1.1

pmol/l

—

7.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.19

0.21

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

7.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

6.9

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.2

—

3771.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

392

1.10

0.21

3.4

3.1

nmol/l

0.8

0.66

305

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.8

—

(3016879) Cocaine [Presence] in Urine

155

1483

1.05

0.20

2.4

2.3

—

(3011648) Oxygen content in Venous blood

251

0.88

0.20

2.3

10.6

11.4

0.38

251

(3015183) Erythrocyte sedimentation rate

192

1.15

0.20

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

441

1.09

0.20

1.5

1.4

mmol/l

61.4

64.6

0.24

361

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.25

0.20

5.5

7.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

1.0

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

202

1.14

0.20

1.0

—

(4094501)

859

1.06

0.20

1.1

—

(4146454)

292

0.89

0.20

3.0

2.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

261

2529

1.03

0.19

4.3

4.0

kpa

6.1

5.9

2.08

256

2455

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.21

0.19

1.0

1.1

102.0

87.9

—

(3017569) Oxygen content in Arterial blood

133

0.83

0.19

4.0

2.5

—

(4306422)

541

1.07

0.18

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.21

0.18

1.0

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.21

0.18

1.0

1.4

—

144.8

—

(40758292) HTLV I+II Ab panel - Serum

1.15

0.17

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.15

0.17

6.7

7.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

141

1354

1.04

0.17

4.7

4.3

mmol/l

24.1

24.2

0.08

125

1233

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

475

0.93

0.17

1.5

1.2

u/l

37.0

46.0

0.23

409

(3045788) Cell count panel - Pleural fluid

224

1.12

0.17

1.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

186

1.13

0.17

1.8

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

803

0.95

0.16

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

120

0.83

0.16

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.18

0.16

6.6

7.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

308

0.91

0.16

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.78

0.15

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.77

0.15

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

100

956

1.05

0.15

3.6

3.8

u/ml

6798.5

1644.5

0.46

832

(3047352) Trisomy 18 risk [Likelihood] in Fetus

616

0.94

0.15

1.5

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2992

29820

1.02

0.15

3.9

3.7

mmol/l

1.3

0.46

2795

27861

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

379

0.92

0.15

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

129

0.85

0.14

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

175

1699

1.03

0.13

1.4

iu/l

24.3

27.0

0.55

153

1453

(3005033) Fetal Nuchal fold Thickness US

612

0.95

0.13

1.4

—

(3051651) Icteric interference index of Serum or Plasma

180

1.11

0.13

3.2

3.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

200

1.10

0.12

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

639

1.05

0.12

1.0

1.1

u/ml

4.7

5.3

0.09

323

(3028707) Methadone [Presence] in Urine by Screen method

698

1.05

0.12

3.6

3.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

434

1.06

0.12

1.0

u/ml

0.0

0.4

2.49

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

114

1.14

0.11

2.2

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

133

1295

1.03

0.10

1.5

1.9

—

(3000285) Sodium [Moles/volume] in Blood

1.11

0.09

1.4

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

135

1.11

0.09

3.3

3.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

210

2060

1.02

0.09

3.9

3.2

kpa

4.7

0.00

204

1993

(3003338) MCHC [Mass/volume]

2750

27428

1.01

0.09

26.0

16.1

g/l

331.5

333.5

25.17

2742

27245

(4198724)

184

1.09

0.09

1.5

3.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

873

1.03

0.08

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

400

0.95

0.08

2.2

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

463

4682

0.99

0.08

1.7

1.8

1.5

1.28

414

4166

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

735

1.03

0.08

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.06

0.08

4.3

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.04

0.08

1.4

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

591

0.96

0.07

1.8

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.03

0.07

1.3

1.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

738

1.03

0.07

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

738

1.03

0.07

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

245

1.06

0.07

1.2

1.0

titre

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

788

1.03

0.07

1.7

—

(3047181) Lactate [Moles/volume] in Blood

897

1.03

0.07

5.9

6.8

mmol/l

1.2

1.3

0.33

777

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.03

0.07

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.02

0.07

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.02

0.07

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

739

1.03

0.06

1.4

—

(40768446) Kidney Pathology biopsy report

138

1.09

0.06

1.7

1.6

—

(3039000) Anion gap in Blood

631

1.03

0.06

7.3

8.0

mmol/l

10.8

11.5

1.27

566

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

119

1.09

0.06

1.0

1.1

—

(3018572) Chloride [Moles/volume] in Blood

632

1.03

0.06

7.3

8.0

mmol/l

105.1

105.3

0.16

567

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

227

1.06

0.06

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

198

1.06

0.05

1.5

1.1

—

(40768793) Breast Pathology biopsy report

546

0.97

0.05

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

356

1.04

0.05

1.2

1.4

pmol/l

100.2

153.7

—

114

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

120

1.08

0.04

1.8

2.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

476

1.03

0.04

1.0

1.1

u/ml

3.0

4.7

0.57

184

(40768795) Lymph node Pathology biopsy report

282

0.96

0.04

1.4

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

615

1.02

0.04

1.0

1.1

u/ml

0.6

1.3

1.06

255

(3014133) Dog dander IgE Ab [Units/volume] in Serum

516

1.03

0.04

1.0

1.1

u/ml

1.9

2.9

0.60

190

(3035933) Granulocytes/100 leukocytes in Blood

101

1.09

0.04

1.0

1.6

—

(3011288) Drugs identified in Urine by Screen method

108

1064

1.02

0.04

4.0

3.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

422

0.97

0.03

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

568

1.02

0.03

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

622

0.98

0.03

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

179

0.95

0.03

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

708

1.02

0.03

1.0

1.1

u/ml

2.5

1.3

0.31

276

(3010726) Horse dander IgE Ab [Units/volume] in Serum

599

1.02

0.02

1.0

1.1

u/ml

3.1

2.4

0.09

142

(3035880) pH of Pleural fluid

132

1.06

0.02

1.6

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

590

1.02

0.02

3.3

3.4

mg/l

19.5

24.1

0.58

372

(1761482) Bacteria [#/volume] in Urine by Culture

610

1.02

0.02

3.5

3.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

620

0.98

0.02

1.1

—

(4268621)

372

1.02

0.01

2.2

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

263

1.03

0.01

1.4

mmol/l

12.6

12.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

124

1.05

0.00

1.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

206

0.97

0.00

1.1

1.0

u/ml

0.2

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

464

1.01

0.00

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

158

1.01

0.00

2.1

—

27.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

182

0.99

0.00

4.7

6.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

189

1.01

0.00

1.1

2.9

—

(3051611) Lipemic interference index of Serum or Plasma

277

1.01

0.00

3.5

3.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

717

1.00

0.00

2.1

2.4

ug/min

93.1

119.8

0.29

456

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

137

1.02

0.00

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

167

1.02

0.00

2.6

2.7

u/ml

689.2

1025.0

0.45

167

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

222.7

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1289.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

1.5

—

(4133840)

0.93

0.00

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.95

0.00

1.0

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.97

0.00

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.00

0.00

1.2

1.4

nmol/l

232.0

138.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.98

0.00

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.92

0.00

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

610

1.00

0.00

1.5

1.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.85

0.00

1.4

3.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.00

0.00

1.3

1.9

ug/l

1.6

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.4

—

4.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

127.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: M13_ANKYLOSPON_ICD10 – Ankylosing spondylitis, ICD10

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ankylosing spondylitis, ICD10

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Ankylosing spondylitis, ICD10 (M13_ANKYLOSPON_ICD10)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints